Cannabis Use Among Patients On Chronic Opioids

Overview

About this study

The purpose of this study is to:

  1. To understand the prevalence of cannabis use among patients on chronic opioids.

  2. To understand how helpful cannabinoids are in the management of different symptoms.

  3. To understand attitudes and beliefs about cannabis among patients on chronic opioids.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Use of chronic opioids

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jon Ebbert, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20402168

Mayo Clinic Footer